One Year On: The Future of CRISPR is Now  As I prepare for my second BIO-International Convention as CEO of ERS Genomics, I’ve taken a moment to reflect on the extraordinary year behind us. CRISPR’s practical impact is accelerating, enabling breakthroughs in treating genetic diseases, engineering more resilient crops, and transforming industrial biotechnology. Every day, researchers use CRISPR to confront some of the world’s most pressing challenges in science, medicine and beyond, reminding us that the future of CRISPR is not tomorrow; it’s already here. Securing our Position in a Challenging IP Landscape  The CRISPR/Cas9 intellectual property landscape remains dynamic,